People · Operator
Named in public records as an officer, director or promoter · active 2019–2025 · Healthtech, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Chronus Health, Inc. | — | Healthtech | Series B | $26.6M | $17.3M | 2019 |
| Faeth Therapeutics, Inc. | — | Biotechnology | Series B | $24.4M | $109.5M | 2025 |
Anand Parikh at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Anand Parikh on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Alex Morgan | 1 | 10 |
| Ajit Singh | 1 | 5 |
| Rishi Reddy | 1 | 4 |
| Robert Gould | 1 | 3 |
| Ryan Flynn | 1 | 2 |
| Jayson Dallas | 1 | 2 |
| Oliver Maddocks | 1 | 1 |
| Ashish Jagtiani | 1 | 1 |
| Stephen Hahn | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.